Equitec Specialists’s Encompass Health EHC Stock Holding History

Equitec Specialists’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-52	Closed	-$2K	–	104
2017 Q2	$2K	Buy	+52	New	+$1.9K	﹤0.01%	102

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Equitec Specialists's EHC Position: Q3 2017 in Review

Equitec Specialists sold out of Encompass Health (EHC) in Q3 2017, closing a stake of 52 shares — an estimated $2K sold.

Equitec Specialists first reported a position in EHC in Q2 2017 and held it in 1 quarter. The position peaked at $2K in Q2 2017. 323 funds tracked by Wall St. Rank hold EHC as of Q3 2017.

Equitec Specialists reported no remaining Encompass Health position as of Q3 2017 after selling out during the quarter.
Equitec Specialists sold 52 Encompass Health shares in Q3 2017, an estimated $2K.
Equitec Specialists first reported a position in Encompass Health in Q2 2017 and held it in 1 quarter.
Equitec Specialists's Encompass Health position peaked at $2K in Q2 2017.
323 funds tracked by Wall St. Rank held Encompass Health as of Q3 2017.

Based on Equitec Specialists's 13F filing for Q3 2017, filed 23 Oct 2017.